PER 5.71% 9.9¢ percheron therapeutics limited

Ann: ATL1103 Phase II Trial - Successful Efficacy Results, page-68

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 266 Posts.
    lightbulb Created with Sketch. 8
    imho the market has already discounted this outcome via the interim results, guessing well end up about where we started today as far as sp. an announcement of a partmership would not have previously discounted and would have moved share price. this was kind of what I expected when I saw results.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.